scispace - formally typeset
D

Domenica Musumeci

Researcher at University of Naples Federico II

Publications -  104
Citations -  2318

Domenica Musumeci is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Nucleic acid & Aptamer. The author has an hindex of 25, co-authored 95 publications receiving 1768 citations.

Papers
More filters
Journal ArticleDOI

An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies

TL;DR: Various approaches recently proposed in the literature to inhibit HMGB1 and the related inflammatory processes are described, especially focusing on the block of RAGE-HMGB1 signaling.
Journal ArticleDOI

G-quadruplex-based aptamers against protein targets in therapy and diagnostics

TL;DR: Recent advancements in SELEX technology for the efficient and rapid identification of new candidate aptamers (introduction of microfluidic systems and next generation sequencing) and discovery of several G4-forming motifs in important regulatory regions of the human or viral genome bound by endogenous proteins are reviewed.
Journal ArticleDOI

Polyvalent nucleic acid aptamers and modulation of their activity: a focus on the thrombin binding aptamer.

TL;DR: The thrombin binding aptamers (TBAs) are analyzed as a model system to study multiple-aptamer constructs aimed at improving their anticoagulation activity in terms of binding to the target and stability to enzymatic degradation.
Journal ArticleDOI

Secosteroids of marine origin

TL;DR: This review describes the isolation from marine organisms of all secosteroids reported in the literature from 1972 to 2004 and gives details on the biological activities of the isolated secosteroid (e.g. antiproliferative, antifouling, antiinflammatory, antimicrobial, ichthyotoxic and antiviral).
Journal ArticleDOI

Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics

TL;DR: An updated overview on fluorescent DNA aptamers, designed to recognize significant cancer biomarkers both in soluble or membrane-bound form are reported, producing tumour-type specific, non-invasive in vivo imaging tools for cancer pre- and post-treatment assessment.